Repligen RGEN 深 滬
交易中 09-20 14:40:03 美东时间
142.56
-3.220
-2.21%
華盛通- 最 高145.20
- 今 開144.52
- 成交量 35.34万股
- 最 低 140.50
- 昨 收 145.78
- 總市值 79.59亿
- 52周最高 211.13
- 市盈率 靜 193.30
- 換手率 0.63%
- 52周最低 110.45
- 委 比 90.99%
- 總股本 5583.20万
- 歷史最高 327.32
- 量 比 0.67
- 振 幅 3.22%
- 歷史最低 2.90
- 每 手 1
- 風險率 22.42%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Repligen Issues Update on Restatement and Maintains Revenue Guidance
The latest update is out from Repligen ( ($RGEN) ). The Company has issued a su...
09-19 04:51
Repligen financial statements require restatement due to revenue recognition error
Repligen (NASDAQ:RGEN) said it will need to restate some of its financial statements after a review found that the timing of recognition of product revenue from a COVID-related cancellation payment wa...
09-19 04:48
Goldman's ‘Goldilocks’ mid-cap picks that trade at reasonable valuations
Goldman Sachs analysts listed 25 mid-cap stocks that have quality and growth attributes and that trade at attractive valuations relative to their history. Each of these companies trade at a next-12-mo...
09-11 23:32
BofA’s global contenders and defenders list
BofA’s listed their global “contender and defender” stocks, a strategy that looks into earnings and price momentum. The bottom-up stock selection model showed preference towards the global financials ...
09-05 02:10
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
Neurocrine Biosciences reports Phase 2 trial results for NBI-1117568 showing significant improvement in schizophrenia symptoms, with an 18.2-point reduction in PANSS scores at a 20 mg dose.
08-28 23:16
Buy Rating Affirmed: Overlooked Long-Term Benefits of Repligen’s Potential Maravai Acquisition
Analyst Justin Bowers from Deutsche Bank maintained a Buy rating on Repligen (R...
08-20 15:17
Repligen Insiders Sell US$10m Of Stock, Possibly Signalling Caution
In the last year, many Repligen Corporation (NASDAQ:RGEN) insiders sold a subst...
08-19 19:02
美股周涨跌榜 | 卫星制造商ASTS周内累涨逾46%！获得50亿美元新业务订单
卫星制造商ASTS周内累涨逾46%！获得50亿美元新业务订单；挖来“救火队长”赴任CEO，星巴克周涨逾27%>>
08-17 15:22
Maravai LifeSciences jumps on report of Repligen takeover offer
Maravai LifeSciences (NASDAQ:MRVI) surged 18% after a report that Repligen (NASDAQ:RGEN) approached the company with a takeover offer. Repligen quickly dropped 7.4%. There's no certainty that Maravai ...
08-16 23:45
Evaluating Macrogenics: Insights From 8 Financial Analysts
Across the recent three months, 8 analysts have shared their insights on Macrog...
08-15 23:01
